The one interview that I didn't listen to all the way through and it contained this -

"In an interview the CEO, Nader Pourhassan said that the FDA asked for a review of the data before disclosing the results."

https://insiderfinancial.com/leronlimab-trial...yn/181078/

Has anyone else noticed that we're up significantly today on no news, albeit on low volume? Buys outpacing sells by roughly 2 to 1 -

https://ih.advfn.com/stock-market/USOTC/cytod...YDY/trades